Brenda Larkin
National Institutes of Health(US)National Institute of Allergy and Infectious Diseases(US)
Publications by Year
Research Areas
Influenza Virus Research Studies, Viral Infections and Outbreaks Research, HIV Research and Treatment, SARS-CoV-2 and COVID-19 Research, Mosquito-borne diseases and control
Most-Cited Works
- → Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine(2013)772 cited
- → Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials(2017)300 cited
- → A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial(2008)272 cited
- → Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial(2022)157 cited
- → Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses(2010)132 cited
- → Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study(2019)125 cited